Anakinra does not seem to improve fatigue severity in women with chronic fatigue syndrome

On March 9, 2017, Posted by , In Buzz, By ,,,,,,, , With No Comments

The anti-inflammatory biologic drug anakinra does not seem to reduce fatigue severity in women with chronic fatigue syndrome (CFS). The findings of a randomized, placebo-controlled trial are published in Annals of Internal Medicine. CFS is characterized by severe, persistent, and disabling fatigue. While case definitions differ, the…